Covered recipient · General Payments record
DAWN M BRINK CYMERMAN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,292.91
- Reported across 61 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $239.25 | 12 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $87.49 | 4 |
| DEXCOM, INC. | $45.48 | 2 |
| Novo Nordisk AS | $30.54 | 2 |
| Insulet Corporation | $22.01 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.57 | 1 |
| Paratek Pharmaceuticals, Inc. | $17.19 | 1 |
| PFIZER INC. | $15.97 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $29.02 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103369273 | CMS |
| ABBVIE INC. | $24.83 | 04/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103369275 | CMS |
| ABBVIE INC. | $17.00 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103369277 | CMS |
| ABBVIE INC. | $16.64 | 09/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103369279 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.57 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1118110797 | CMS |
| Dexcom, Inc. | $23.91 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153295691 | CMS |
| Dexcom, Inc. | $21.57 | 09/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153295693 | CMS |
| Insulet Corporation | $22.01 | 04/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116798665 | CMS |
| Novo Nordisk Inc | $16.74 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097668336 | CMS |
| Novo Nordisk Inc | $13.80 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096826744 | CMS |
| Paratek Pharmaceuticals, Inc. | $17.19 | 03/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1113893883 | CMS |
| PFIZER INC. | $15.97 | 07/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131772569 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.